Scientific Advisory Board

About this role

Our Mission

Axonis Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.

Scientific Advisory Board

YVES DE KONINCK, Ph.D.

Chair of Scientific Advisory Board

COREY GOODMAN, Ph.D.

Executive Chairman, Co-Founder & Scientific Advisor

ZHIGANG HE, Ph.D.

Scientific Advisor, KCC2 Neurobiology and Neurotrauma

CLIFFORD WOOLF, Ph.D.

Scientific Advisor, Pain

JACQUELINE FRENCH, M.D.

Scientific Advisor, Clinical Epilepsy

ROGER PORTER, M.D.

Scientific Advisor, Epilepsy & Clinical Pharmacology

LISA MCKERRACHER, Ph.D.

Scientific Advisor & Co-Founder

JAMES GUEST, M.D., Ph.D., FACS

Scientific Advisor, Clinical Spinal Cord Injury

WOLFGANG LIEDTKE, M.D., Ph.D.

Scientific Advisor, KCC2 Neurobiology and Pain